Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks
In other words, when taken orally, it has no adverse side effects
You will be required to upload or submit your prescription during the checkout process
For example, the injections are not recommended for patients who are not clinically overweight with a BMI of 27 or more
Whether you are dealing with a missed dose, managing side effects, or wondering if it is time to adjust your dosage, having 24/7 access to specialist support ensures you never have to guess about your health
All you need to know Key highlights Most Aetna plans cover Zepbound for weight loss as a preferred drug
US$ 26.02
US$ 27.40
US$ 29.39
US$ 27.14
US$ 20.90
